FOF/VC  DSM Venturing ntities/dsm-venturing.html

     Office Locations:

1 Broadway, 14th Floor
Cambridge, MA 02142
Phone: 617-531-2129

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.


  • Early
  • Expansion



  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial



    Headquartered in the Netherlands, DSM Venturing is an active investor in start-up companies. The firm looks for innovative products and services in Life Sciences and Materials Sciences in the fields Climate & Energy, Functionality & Performance, Health & Wellness, and Emerging Economies. DSM Venturing's mission is to explore emerging markets and technologies in order to support DSM's innovation and growth strategy. DSM Venturing participates in early and expansion stage companies or venture capital funds as a value adding partner. The firm's investments typically range between EURO 0.5 and EURO 5 million (no fixed upper limit). DSM's share target range in companies is 10% to 25% share. The firm currently has about EURO 60 million invested in promising companies and leading venture capital funds. DSM goes where the growth is, focusing on regions that generate the most opportunities, including China, India, Russia, and Brazil.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Casper Bruens Senior investment Manager
    Erik Rutten Senior Investment Manager
    Greg McParland Investment Manager
    Ian Freelance Senior investment Manager
    Pieter Wolters Managing Director


    Recent Funding Events (trailing 12 months):







      MIACH Orthopaedics



      Series A


      Chromatic 3D Materials



      Series A


    Portfolio companies include:

        web link

      Bioprocess Control
        web link

        web link

        web link

      Chromatic 3D Materials
        web link

      Ganeden Biotech
        web link

      Harland Medical Systems
        web link

        web link

      IntegraGen SA
        web link

      IQ Therapeutics
        web link

      MIACH Orthopaedics

        web link

        web link

        web link

        web link

      Regentis Biomaterials
        web link

        web link

      SkySails GmbH & Co
        web link

      Sol-Gel Technologies
        web link

        web link

        web link

      Tianjin Green Bio-Science
        web link

      Upfront Chromatography
        web link

      Van Technologies
        web link

        web link

        web link

        web link

        web link

      ZeaVision Holdings
        web link


    Recent News: